MediciNova Inc - Company Profile
Powered by 
All the sales intelligence you need on MediciNova Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how MediciNova Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with MediciNova Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on MediciNova Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4284366A1 | Application | Verfahren zur behandlung von chemischer gasexposition | A61K31/437; A61K31/56; A61P11/00 | December 06, 2023 |
| EP3139911B1 | Grant | Procédé de traitement d'une stéatohépatite non alcoolique avancée | A61K31/05; A61K31/075; A61K31/085; A61K31/095; A61K31/10; A61K31/121; A61K31/122; A61K9/0053; A61K9/08; A61K9/20; A61K9/48; A61P1/16; C07C323/22 | October 25, 2023 |
| EP3740205B1 | Grant | Verfahren zur unterdrückung von myeloidabgeleiteten suppressorzellen in patienten | A61K31/437; A61K9/0053; A61P31/00; A61P35/00; A61P37/00 | September 20, 2023 |
| US20230285367A1 | Application | Methods of treating post-covid condition(S) | A61K31/437; A61K45/06; A61P25/28; A61P31/14; A61P43/00 | September 14, 2023 |
| CA2946597C | Grant | Method of treating advanced non-alcoholic steatohepatitis | A61K31/05; A61K31/075; A61K31/085; A61K31/095; A61K31/10; A61K31/121; A61K31/122; A61K9/0053; A61K9/08; A61K9/20; A61K9/48; A61P1/16; C07C323/22 | September 12, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer